Role of niacin in current clinical practice

Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

(2018) Emelia J. Benjamin et al.   CIRCULATION

Cardiovascular outcomes during extended follow-up of the AIM-HIGH trial cohort

(2018) Jeffrey L. Probstfield et al.   Journal of Clinical Lipidology

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase

(2016) Peter Würtz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies

(2015) Richard Kones et al.   DRUGS

Detrimental effects of niacin/laropiprant on microvascular reactivity and red cell deformability in patients with elevated lipoprotein(a) levels

(2015) Gabriele Cioni et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease

(2014) Paul T. Williams et al.   ATHEROSCLEROSIS

Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Recent advances in niacin and lipid metabolism

(2013) Vaijinath S. Kamanna et al.   CURRENT OPINION IN LIPIDOLOGY

Levels of Cholesterol in Small LDL Particles Predict Atherosclerosis Progression and Incident CHD in the HDL-Atherosclerosis Treatment Study (HATS)

(2013) Paul T. Williams et al.   PLoS One

Nicotinic Acid Has Anti-atherogenic and Anti-inflammatory Properties on Advanced Atherosclerotic Lesions Independent of its Lipid-modifying Capabilities

(2011) Eva Holzhäuser et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Evidence That Niacin Inhibits Acute Vascular Inflammation and Improves Endothelial Dysfunction Independent of Changes in Plasma Lipids

(2010) Ben J. Wu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION